Close Menu
Home » Patient's NIPT Cancer Dx Highlights Lack of Standards for Consent, Return of Secondary Findings

Patient's NIPT Cancer Dx Highlights Lack of Standards for Consent, Return of Secondary Findings

Mar 10, 2015
|
Molika Ashford
Premium

NEW YORK (GenomeWeb) - As a woman of "advanced maternal age," Eunice Lee, a practicing anesthesiologist, knew when she gave a blood sample for non-invasive prenatal testing that she might find out her 10-week old fetus had a chromosomal disorder. But she didn't imagine she could potentially learn something troubling about her own health.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Test of Antibodies

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

New York Rats Through and Through

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Powerhouse of the Cell, Lost

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

Science Papers Discuss AI in Drug Discovery, Find Two Red Panda Species

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. CDC Revises SARS-CoV-2 Assay Protocol; Surveillance Testing on Track to Start Next Week

  2. Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

  3. PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England

  4. Congressional Caucus Working to Raise Personalized Medicine Awareness Among Legislators

    Premium

  5. Guardant Health to Focus on Early Cancer Detection and Monitoring, CDx Development in 2020

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.